Navigation Links
2005 was a tough year for U.S. biotech financing

As we are still in January, it is appropriate that we continue to review biotech results for 2005 and try to find lessons learned that might help us discern trends for 2006.

Another research tool I have always found useful for this analysis is Burrill & Co.'s financial tracking information on the biotech industry. On......

Full article >>> ded in Burrill's review, as Burrill focuses principally on drugs versus medical devices).

Another interesting trend that Burrill notes is M&A activities. We have all been filing the high profile bidding war in the beginning of 2006 (which actually started in 2005) between Boston Scientific/Abbott Labs and J&J to acquire Guidant; at this writing, it appears that Boston Scientific/Abbott La......

Full article >>> companies, struggling with their pipelines and potential generic intrusion as patents come to an end on key products.

Let's look at Burrill's information on the different channels of biotech financing in 2005:

U.S. biotech financing in 2005 ($millions)
Type of Financing20042005% Change
Public
Full article >>> n the U.S. Remember that this applies to a little more than the 300 publicly-traded biotech companies in the U.S.

VC financing of $3.5 billion in 2005 was down 7 percent. This result is bad news for the 1200+ privately held biotech companies in the U.S. that depend mostly on VC financing. Assuming the number of 1200 companies, the average raise-up per company was less than $3 million in ......

Full article >>> and early stage life science companies such as Renovar, a Wisconsin-based in-vitro diagnostics company. Rosen is also a founder and board member of the Illinois Biotechnology Industry Organization. He can be reached at rosenmichaels@aol.com

This article has been syndicated on the Wisconsin Technology Netw......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 01/30/06


Related biology technology :

1. The tough choices facing health care
2. Venture-backed companies drive job creation, even in tough times
3. Vertical partnering: Street smarts for a tough marketplace
4. The state of global biotech: An Ernst & Young perspective
5. Olympics of biotechnology has international flavor
6. Getting noticed in Genetown: Wisconsin biotech on display
7. Madison biotech NimbleGen files for IPO; one of states best-funded firms
8. Wisconsin biotech firm receives $107K NIH grant
9. Manufacturing partnership will move into biotech and biomedical spaces
10. Wisconsin wont get Georgia biotech without a fight
11. The 10 biggest events shaping biotech in 2006
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/18/2017)... ... 18, 2017 , ... When James Sherley, was notified earlier this year that his company ... Year 2017 by The Silicon Review , he was not surprised as others might ... value, but this recognition by Silicon Valley was particularly meaningful. Our selection ...
(Date:5/16/2017)... ... May 16, 2017 , ... ... ProxiMeta™ Hi-C metagenomic deconvolution service. ProxiMeta enables researchers to obtain complete, distinct ... research insights at lower cost. , “We’re very excited about the commercial ...
(Date:5/16/2017)... ... May 16, 2017 , ... Cynvenio Biosystems, ... its ClearID Lung Cancer blood test. Leveraging a highly-sensitive next-generation sequencing panel of ... designed to quickly and accurately identify tumor-related genetic mutations that can be treated ...
(Date:5/16/2017)... (UK) , ... (PRWEB) May ... ... Annual Congress of the Chinese Association of Orthopaedic Surgeons (CAOS), long-standing development ... Medical") collaborated on an interbody spine surgery workshop to help expand knowledge ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
Breaking Biology News(10 mins):